JANNETTE
RODRIGUEZ PALLARES
Profesora titular de universidade
JOSE LUIS
LABANDEIRA GARCIA
Catedrático de universidade
Publicacións nas que colabora con JOSE LUIS LABANDEIRA GARCIA (48)
2024
-
Non-HLA angiotensin-type-1 receptor autoantibodies mediate the long-term loss of grafted neurons in Parkinson’s disease models
Stem Cell Research and Therapy, Vol. 15, Núm. 1
2023
-
Combined cell-based therapy strategies for the treatment of Parkinson's disease: Focus on mesenchymal stromal cells
Neural Regeneration Research, Vol. 18, Núm. 3, pp. 478-484
2021
-
Dopamine regulates adult neurogenesis in the ventricular-subventricular zone via dopamine D3 angiotensin type 2 receptor interactions
Stem Cells, Vol. 39, Núm. 12, pp. 1778-1794
-
Dose-dependent effect of mesenchymal stromal cells co-grafted with dopaminergic neurons in a Parkinson's disease rat model
Journal of Cellular and Molecular Medicine, Vol. 25, Núm. 20, pp. 9884-9889
-
Nrf2 activation and downstream effects: Focus on parkinson’s disease and brain angiotensin
Antioxidants, Vol. 10, Núm. 11
2019
2018
-
Angiotensin II induces oxidative stress and upregulates neuroprotective signaling from the NRF2 and KLF9 pathway in dopaminergic cells
Free Radical Biology and Medicine, Vol. 129, pp. 394-406
-
Data on the effect of Angiotensin II and 6-hydroxydopamine on reactive oxygen species production, antioxidant gene expression and viability of different neuronal cell lines
Data in Brief
-
Prostaglandin EP2 Receptors Mediate Mesenchymal Stromal Cell-Neuroprotective Effects on Dopaminergic Neurons
Molecular Neurobiology, Vol. 55, Núm. 6, pp. 4763-4776
2017
-
Brain renin-angiotensin system and microglial polarization: Implications for aging and neurodegeneration
Frontiers in Aging Neuroscience, Vol. 9, Núm. MAY
-
Laser capture microdissection protocol for gene expression analysis in the brain
Histochemistry and Cell Biology, Vol. 148, Núm. 3, pp. 299-311
2016
-
Effects of rho kinase inhibitors on grafts of dopaminergic cell precursors in a rat model of Parkinson’s disease
Stem Cells Translational Medicine, Vol. 5, Núm. 6, pp. 804-815
2015
-
Interaction between NADPH-oxidase and Rho-kinase in angiotensin II-induced microglial activation
GLIA, Vol. 63, Núm. 3, pp. 466-482
-
Reciprocal regulation between sirtuin-1 and angiotensin-II in the substantia nigra: Implications for aging and neurodegeneration
Oncotarget, Vol. 6, Núm. 29, pp. 26675-26689
2014
-
Brain renin-angiotensin system and dopaminergic cell vulnerability
Frontiers in Neuroanatomy, Vol. 8, Núm. JULY
2013
-
Brain angiotensin regulates iron homeostasis in dopaminergic neurons and microglial cells
Experimental Neurology, Vol. 250, pp. 384-396
-
Dopamine-Angiotensin interactions in the basal ganglia and their relevance for Parkinson's disease
Movement Disorders, Vol. 28, Núm. 10, pp. 1337-1342
2012
-
2-Benzazepine nitrones protect dopaminergic neurons against 6-hydroxydopamine-induced oxidative toxicity
Archiv der Pharmazie, Vol. 345, Núm. 8, pp. 598-609
-
Brain angiotensin and dopaminergic degeneration: Relevance to Parkinson’s disease
American Journal of Neurodegenerative Diseases, Vol. 1, Núm. 3, pp. 226-244
-
Cografting of carotid body cells improves the long-term survival, fiber outgrowth and functional effects of grafted dopaminergic neurons
Regenerative Medicine, Vol. 7, Núm. 3, pp. 309-322